TYROBP and bone disorder: Homozygous mutations in TYROBP (encoding the TREM2 ligand DAP12) or TREM2 cause Nasu–Hakola disease associated with progressive, early-onset dementia, bone cysts, and demyelinating lesions in the CNS (Paloneva et al., 2002).